• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

用于评估血浆蛋白组分治疗效果的血友病犬模型

Hemophilic dog model for evaluating therapeutic effectiveness of plasma protein fractions.

作者信息

Kingdon H S, Hassell T M

出版信息

Blood. 1981 Nov;58(5):868-72.

PMID:6794675
Abstract

Therapeutic effectiveness of factor VIII inhibitor bypassing materials has been evaluated in dogs with hemophilia A. A standardized template gingival biopsy was performed using local anesthesia. Hemophilic dogs bled extensively from the biopsy site, whereas in normal dogs the wound was sealed within 5 + /- 2 min. If untreated, the hemophilic dogs frequently bled for several days. Factor VIII infusion stopped the bleeding promptly. Some experimental preparations of factor VIII inhibitor bypassing materials were shown to be therapeutically effective, whereas others were not. Intravascular thrombi could not be demonstrated histologically. The model should prove useful for evaluating factor VIII inhibitor bypassing materials and also for evaluating their mechanism of action.

摘要

已在患有A型血友病的犬中评估了凝血因子VIII抑制剂旁路制剂的治疗效果。使用局部麻醉进行标准化的牙龈活检模板操作。血友病犬从活检部位大量出血,而正常犬的伤口在5±2分钟内就会愈合。如果不进行治疗,血友病犬经常会出血数天。输注凝血因子VIII可迅速止血。一些凝血因子VIII抑制剂旁路制剂的实验制剂显示出治疗效果,而其他制剂则没有。组织学检查未发现血管内血栓形成。该模型应证明对评估凝血因子VIII抑制剂旁路制剂及其作用机制有用。

相似文献

1
Hemophilic dog model for evaluating therapeutic effectiveness of plasma protein fractions.用于评估血浆蛋白组分治疗效果的血友病犬模型
Blood. 1981 Nov;58(5):868-72.
2
Hemophilic dogs response to Bridge anticoagulant neutralizing agent.血友病犬对桥接抗凝中和剂的反应。
Transfusion. 1983 Nov-Dec;23(6):533-4. doi: 10.1046/j.1537-2995.1983.23684074281.x.
3
Factor VIII-bypassing activity of bovine tissue factor using the canine hemophilic model.利用犬血友病模型研究牛组织因子的VIII因子旁路活性。
J Clin Invest. 1988 Jul;82(1):206-11. doi: 10.1172/JCI113571.
4
Purified human factor VIII procoagulant protein: comparative hemostatic response after infusions into hemophilic and von Willebrand disease dogs.纯化的人凝血因子VIII促凝血蛋白:输注到血友病和血管性血友病犬后比较止血反应
Proc Natl Acad Sci U S A. 1985 Dec;82(24):8752-6. doi: 10.1073/pnas.82.24.8752.
5
Clearance of cryoprecipitated factor VIII in canine hemophilia A.犬血友病A中冷沉淀凝血因子VIII的清除率
Am J Vet Res. 1975 Apr;36(4 Pt.1):367-70.
6
Use of prothrombin complex concentrates in the treatment of a hemophilic patient with an inhibitor of factor VIII.凝血酶原复合物浓缩剂在治疗一名患有VIII因子抑制物的血友病患者中的应用。
Blood. 1976 Jun;47(6):983-9.
7
A canine model of hemophilic (factor VIII:C deficiency) bleeding.血友病(因子VIII:C缺乏)出血的犬类模型。
Blood. 1982 Sep;60(3):727-30.
8
Kinetic analysis of bovine factor VIII in the hemophilic dog.
Thromb Haemost. 1981 Aug 28;46(2):485-8.
9
Prothrombin complex concentrate (Konyne) in the treatment of hemophilic patients with factor VIII inhibitors.
J Pediatr. 1976 Feb;88(2):200-5. doi: 10.1016/s0022-3476(76)80982-1.
10
Development of factor VIII:C antibodies in dogs with hemophilia A (factor VIII:C deficiency).
Blood. 1984 Feb;63(2):451-6.

引用本文的文献

1
Lessons Learned from Animal Models of Inherited Bleeding Disorders.从遗传性出血性疾病动物模型中获得的经验教训。
Hematol Educ. 2014 Jun;8(1):39-46.
2
A new mouse model for wound healing in hemophilia A.一种用于甲型血友病伤口愈合的新型小鼠模型。
Int J Clin Exp Pathol. 2015 Mar 1;8(3):3015-21. eCollection 2015.
3
A review of current methods for assessing hemostasis in vivo and introduction to a potential alternative approach.目前评估体内止血的方法综述及一种潜在替代方法的介绍。
Thromb Res. 2012 May;129 Suppl 2(0 2):S57-61. doi: 10.1016/j.thromres.2012.02.035. Epub 2012 Mar 8.
4
Adeno-associated virus vectors and hematology.腺相关病毒载体与血液学
Blood. 1999 Aug 1;94(3):864-74.
5
Use of human factor VIIa in the treatment of two hemophilia A patients with high-titer inhibitors.人凝血因子VIIa在两名高滴度抑制物血友病A患者治疗中的应用。
J Clin Invest. 1983 Jun;71(6):1836-41. doi: 10.1172/jci110939.